Smelly, I think the whole "banned" crew is here today :) As

New Post Public Reply Private Reply Replies (1) Message Board
Diamond42 smellythedwarf #260
Smelly, I think the whole "banned" crew is here today As far as good dd, I wanted everyone to remember the sticky from StervC. Although we all hide under the blanket of anonymity on these message boards I do take Stervc's dd seriously so I figured I would post it here for people to remember....

CRGP .20+ Actual Fundamental Valuation to Consider

Usually whenever I create a fundamental valuation post, it is derived from speculation predicated upon the ”potential” that exists of a company to becoming profitable upon executing their business objectives.

However, here with CRGP, this fundamental valuation will not be based upon its ”potential” revenues for being profitable, but instead will be based upon its ”actual” revenues that have been generated to a level to where CRGP is profitable. This means that this valuation will lean more towards being ”factual” versus ”speculation” based on what has been filed within the company’s financials. Let’s further observe some ”Key Variables” within the Annual Report and the last two Quarterly Reports to include its most recent Quarterly Report filed on Aug 19, 2015 to show the consistency of sustained growth.



For the year ending Dec 31, 2014, CRGP reported the following key variables to consider:
http://www.otcmarkets.com/financialReportView...;id=135644
Assets = $19,908,111
Liabilities = $7,105,629
Equity = $12,802,482

Revenues = $15,693,666
Expenses = $7,248,635 + $669,512
Net Income = $7,775,519



For the quarter ending Mar 31, 2015, CRGP reported the following key variables to consider:
http://www.otcmarkets.com/financialReportView...;id=138139
Assets = $19,650,272
Liabilities = $4,711,927
Equity = $14,938,345

Revenues = $5,035,867
Expenses = $2,711,621 + 194,383
Net Income = $2,129,863



For the quarter ending Jun 30, 2015, CRGP reported the following key variables to consider:
http://www.otcmarkets.com/financialReportView...;id=143463
Assets = $21,080,227
Liabilities = $4,688,677
Equity = $18,193,345

Revenues = $8,907,600
Expenses = $4,809,105 + 283,200
Net Income = $3,815,295



Net Income (Profit) Margin = $3,815,295 ÷ $8,907,600 = 42.8%

The beauty about CRGP is that the company has reflected consistent growth as can be confirmed from the key variables within its Annual and Quarterly Reports above. Now let’s derive an annual fundamental valuation considering that the San Pedro Mine has recently been sold from the quarterly revenues above and by considering the quarter to quarter growth for this year of 2015. This means that to get an ”actual” fundamental valuation, we must consider only the revenues of the remaining Jovita Mine going forward for now.

http://www.otcmarkets.com/financialReportView...;id=138139
$3,147,417 = Jovita Mine for the quarter ending Mar 31, 2015
($2,580,882 + 566,535)

http://www.otcmarkets.com/financialReportView...;id=143463
$6,180,200 = Jovita Mine for the quarter ending Jun 30, 2015
($5,344,560 + 835,640)

Now let’s derive an annual amount considering only the revenues from the Jovita Mine and considering that the revenues only remain constant/consistent even though thus far the revenues have been exponentially growing at a doubling rate per quarter for 2015.

$6,180,200 x 4 Qtrs = $24,720,800

$24,720,800 x .428 Net Profit Margin = $10,580,502 Net Income

The Outstanding Shares (OS) is the key fundamental denominator that is used to assess the fundamental valuation of a company to help derive the Earnings Per Share (EPS) for a company. To derive an EPS for CRGP, we must know the OS and the Net Income amounts. The last reported number for the OS was 242,823,237 shares within the Aug 13, 2015 PR below:
http://www.otcmarkets.com/stock/CRGP/news/Cal...33&b=y

As a ”worst case scenario” for the OS, let’s consider the OS to be roughly 3 times that amount and round the OS to being 750,000,000 shares for the purpose of this post since the announcement above. Please use the Substitution Property to substitute out any variable that might change later in the future such as the amount of Net Income or particularly the amount for the OS if it is higher or lower than the number I’m considering for the purpose of this post.

CRGP is on schedule to generate at least $10,580,502 in Net Income over the next four quarters. This gives us logic to derive a valuation from the related formulas indicated below:

Net Income ÷ Outstanding Shares (OS) = Earnings Per Share (EPS)

So…

$10,580,502 Net Income ÷ 750,000,000 shares (OS Worst Case) = .0141 EPS

To determine where a stock should fundamentally trade, multiply the EPS with the Price to Earnings (P/E) Ratio. For inquiring minds, the P/E Ratio is basically the ”Growth Rate” for a group of similar stocks within a particular Sector or Industry for where a stock would be classified to exist/trade. As that stock exists within that particular Sector or Industry, it is expected to grow at the same rate as such like stocks within that Sector or Industry. For those new for understanding what a P/E Ratio is, read the links below that hopefully will help:

Calissio Resources Group, Inc. (CRGP) Stock Research Links

CRGP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 90

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Ping An Shows Resilient Growth Amid Economic Pressure

Updated Category News Views 18

Unpacking Ping An's Steady Climb Amid Tumult A few eyebrows might have raised when Ping An Insurance unveiled its nine-month report for 2026. Despite economic turbulence in China—courtesy of a gnarly global scene—the numbers were anything but rattled. Operating profit rose 8.3% year over year to a beefy RMB125,905 million. The equity pool swelled by 4.4% as of...

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 69

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 86

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 98

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 100

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 0

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 14

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 0

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
Digimon Card Game Ventures into Digital Realms

Updated Category News Views 40

A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Ripple Banking License: Unlocking New Opportunities for XRP

Updated Category News Views 129

Ripple Banking License: Unlocking New Opportunities for XRP In recent developments, Ripple is on the brink of obtaining a banking license, a significant milestone that promises to reshape its role within the traditional financial sector. This pivotal moment not only ratifies Ripple’s credibility but also enhances the use of XRP among its holders. The acquisition of a...

Continue Reading
SEI's Dividend: $0.52 a Share May 2026 Call

Updated Category News Views 22

SEI's Dividends Sweeten the Pot In a world where every market shift feels like someone moving your chair just as you sit down, SEI Investments (NASDAQ: SEIC) keeps a consistent beat. They've declared a semi-annual dividend of $0.52 per share, and let me tell you, that's music to any income-seeking investor's ears right now. Those looking for steady returns in this...

Continue Reading
Solana Experiences a Significant Price Surge of 6.18%

Updated Category News Views 48

Solana price jumps 6.18% to $134.95 Solana added 6.18% in the latest session, bringing the price to $134.95. The move points to firm trading momentum as the market keeps a close eye on SOL. Gains like this usually appear when interest broadens and activity picks up, even if the day-to-day path isn’t perfectly smooth. One-week trend: steady gains from $130.33 Beyond the...

Continue Reading
BD Strengthens Future Plans with Strategic Business Separation

Updated Category News Views 1181

BD Announces Strategic Separation of Business Units BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has taken a bold step by announcing a plan to separate its Biosciences and Diagnostics Solutions divisions from the rest of the organization. This strategic separation aims to enhance focus, drive growth, and unlock substantial...

Continue Reading
Understanding Solana's Recent Price Decline and Market Impact

Updated Category News Views 273

Analyzing Solana's Price Drop In the last day, Solana has encountered a significant decrease in its price, falling by more than 9% and currently valued at $120.87. This price drop is part of a broader downward trend observed over the past week, where the cryptocurrency recorded a staggering loss of 22%. The decline in value from $157.77 to its present figure illustrates...

Continue Reading